Your session is about to expire
← Back to Search
Pain Control Methods for Ankle Surgery (PvP Trial)
PvP Trial Summary
This trial will study two common procedures for controlling pain after ankle surgery.
PvP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPvP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PvP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been taking strong painkillers for a long time before the surgery.I have been diagnosed with chronic pain syndrome.My surgery will be done in a hospital.You have had allergic reactions to certain numbing medications that are given by injection.I have been diagnosed with peripheral neuropathy.My surgery is scheduled at Campbell Surgery Center in Germantown, TN.I have had surgery to correct bone structure in my ankle or to repair a broken ankle.I can follow the study's rules and attend all required visits.I am between 18 and 80 years old.
- Group 1: Periarticular Injection
- Group 2: Popliteal Block
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current amount of participants in this trial?
"At present, this research protocol is not enrolling any new participants. The initial posting was on July 13th 2021 with the most recent update occurring in October 14 2022. If you are searching for alternative studies, there are presently 4 clinical trials recruiting patients suffering from foot pain and 109 medical investigations currently admitting individuals requiring Periarticular Injections."
Is recruitment still happening for this clinical trial?
"Based on the data available on clinicaltrials.gov, this trial is not presently seeking participants as it was last updated in October of 2022. Nevertheless, 113 other studies are actively admitting applicants at this juncture."
Has Periarticular Injection received clearance from the FDA?
"With Phase 4 trials affirming Periarticular Injection's efficacy, our team at Power has rated its safety as a 3 on a scale from 1 to 3."
What maladies tend to be treated using Periarticular Injection?
"Permphigus is usually managed with the use of Periarticular Injection. This method can also be employed to mitigate acute nonspecific tenosynovitis, general anesthesia and lupus erythematosus cell symptoms."
Who has been deemed most suitable for inclusion in this experiment?
"Eligibility criteria for the trial require prospective participants to have a certain medical condition and be between 18-80 years of age. There is space for roughly one hundred individuals in this investigation."
Is the age restriction on this trial inclusive to minors?
"According to the eligibility parameters, all prospective participants ought to be aged 18 or above and 80 or below."
Can you provide an overview of the prior research done on Periarticular Injection?
"As of now, 109 medical trials are researching Periarticular Injection with 18 entering Phase 3. Of these studies, Philadelphia Pennsylvania is hosting several; however, there are 144 clinical sites involved in total."
Could you please elucidate the primary aims of this research project?
"The primary endpoint of this 12 week trial is to analyse the degree of motor block. The secondary outcomes involve patient reported satisfaction with their pain management on a seven-point likert scale, whether they experience neuralgia symptoms, and what kind of postoperative medication was prescribed."
Share this study with friends
Copy Link
Messenger